Akero Therapeutics Inc buy Cantor Fitzgerald
Start price
04.10.23
/
50%
€43.60
Target price
04.10.24
€65.81
Performance (%)
-41.47%
End price
05.10.24
€25.52
Summary
This prediction ended on 05.10.24 with a price of €25.52. Massive losses of -41.47% were the result for the BUY prediction by Cantor_Fitzgerald. Cantor_Fitzgerald has a follow-up prediction for Akero Therapeutics Inc where he still thinks Akero Therapeutics Inc is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | - | - | - |
| iShares Core DAX® | 0.224% | 2.031% | 21.399% |
| iShares Nasdaq 100 | 0.371% | -0.955% | 5.637% |
| iShares Nikkei 225® | 0.972% | -0.953% | 13.432% |
| iShares S&P 500 | 0.417% | -0.622% | 3.310% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $69.00 price target on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Akero Therapeutics Inc
Stopped prediction by Cantor_Fitzgerald for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€20.34
20.06.24
20.06.24
-
20.06.25
20.06.25
131.22%
21.06.25
21.06.25
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€23.57
12.06.24
12.06.24
-
12.06.25
12.06.25
96.48%
13.06.25
13.06.25
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€13.80
11.10.23
11.10.23
€36.75
11.10.24
11.10.24
95.65%
12.10.24
12.10.24
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€48.20
19.09.23
19.09.23
€64.47
19.09.24
19.09.24
-48.36%
20.09.24
20.09.24